Financial News
Latest News about CYBN
Recent news which mentions CYBN
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
August 16, 2023
Tickers
CYBN
From Benzinga
Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic
August 14, 2023
Tickers
CYBN
From Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
From Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
From Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 01, 2023
From Benzinga
Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal
August 01, 2023
From Benzinga
US Stocks Mixed; Pfizer Earnings Beat Views
August 01, 2023
From Benzinga
Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
August 01, 2023
From Benzinga
From InvestorPlace
From Benzinga
A Quantum Leap In Psychedelic Research: Study Shows Real-Time Brain Changes After Ketamine Use
July 21, 2023
Tickers
CYBN
From Benzinga
Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session
July 06, 2023
From Benzinga
From Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
June 28, 2023
Tickers
CYBN
From Benzinga
TOMS Shoes founder is pledging $100 million for psychedelic research – Here’s why he’s doing it.
June 21, 2023
From MarketWatch
Stocks That Hit 52-Week Lows On Tuesday
June 06, 2023
From Benzinga
Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More
June 06, 2023
From Benzinga
From Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
May 24, 2023
Tickers
CYBN
From Benzinga
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
May 15, 2023
From Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
From Benzinga
From Benzinga
From Benzinga
Cybin, Mind Medicine Among Top Psychedelic Movers Of Today
April 19, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.